Evidence and strategy
Avalere Health supports your value proposition and evidence generation throughout the product lifecycle.
Why choose us?
Actionable insights, comprehensive support
An unparalleled team of experts to support your value proposition and evidence generation.
Our interdisciplinary, cross-sector team provides actionable insights that optimize our clients’ market opportunity. We apply deep expertise in HEOR, evidence generation, mixed-methods research, value assessment, and quality improvement to:
- Support patient-centered outcomes
- Interpret and apply findings from large-scale, real-world data
- Craft effective communication strategies
- Effectively convey value differentiation for plans, providers, and payments
With decades of industry experience and a track record offering comprehensive evidence and strategy support to all top-25 life sciences companies and 100+ indications, we know what it takes to turn insight into impact.
What we offer
Our deep HEOR expertise pairs strategic advising with data-driven analytics and evidence generation for US and ex-US markets.
Primary research
- Patient and caregiver interviews, focus groups, and surveys
- Patient preference studies
- Indirect burden of disease assessments
- Provider and payer stakeholder interviews
- Provider behavior studies
- Delphi panels
- Advisory boards
HEOR strategy and planning
- Evidence generation planning and HEOR roadmap development
- Data partnership evaluation
- HEOR landscape assessments
- Integrated commercial/HEOR planning
- HTA and regulatory support
- AMCP and global value dossier development
Value assessment strategy and planning
- Value assessment planning, strategy, and response
- Inflation Reduction Act evidence planning, submission, preparation, and strategy
- Foundational value assessment education
- Environmental and policy monitoring
- Cross-functional alignment and enterprise-wide value assessment and evidence strategy
Real–world data analytics
- Claims-based analytics
- Patient journey and diagnostic odyssey
- Healthcare resource utilization, patterns, and expenditures
- Health disparities research
- Epidemiological studies
- Post-market surveillance
- Commercial analytics
- Predictive modeling
Economic modeling and synthesis
- Cost effectiveness and budget impact modeling
- Early economic modeling
- Cost benefit analysis
- Cost of illness modeling
- Simulation models
- Parameterization and clinical trial analytics
- Systematic and targeted literature reviews
- Indirect treatment comparisons
- Meta-analysis
- Economic model validation
Our approach
Insight from every angle
Our Evidence and Strategy team works with US and global HEOR teams at every step of the product lifecycle.
Clients rely on us to navigate changing landscapes through evidence and strategy that is deeply rooted in their specific clinical and commercial context. We also work closely with teams that are evolving existing evidence strategies, providing analytic insights through qualitative and quantitative research. We elevate these findings via robust data access, including 100% Medicare Part A/B/C/D data via an agreement with CMS, longitudinal closed claims data, and Planscape®, comprehensive formulary and benefit design data.
We ensure that your evidence reaches EVERY PATIENT POSSIBLE through close collaboration with in-house medical communications and market access experts, providing an integrated evidence development, medical communications, and commercialization plan.
Who we help
Pharmaceutical manufacturers
Emerging biotech companies
Diagnostic and device manufacturers
Managed care organizations
Payers
Benefit vendors
Our work
How we have helped clients
Case study
Applying patient preferences in treatment for triple negative breast cancer to value assessment
A top-15 pharmaceutical company sought Avalere Health’s support in understanding patient perspectives and preferences for treatment of TNBC. Through primary research, we examined characteristics of treatment that patients value and applied these findings to the current US value assessment landscape to highlight where patient preferences are and are not incorporated in various value frameworks.
Discover moreCase study
Examining the association of SDOH with outcomes in patients with pulmonary arterial hypertension
We supported an HEOR team at a Public Benefit Corporation in assessing how social determinants of health and geography characteristics of patients with PAH impact care, treatment patterns, and outcomes. Through a claims-based analysis, we identified social and geographic barriers to care for patients with PAH, which highlights the need for patient-centered drug development, diverse clinical trial recruitment and site selection, and targeted field outreach.
Discover moreCase study
Developing an HEOR evidence generation strategy to support product launch
A biopharmaceutical company needed an evidence generation strategy to support the commercial launch of two pipeline assets. Avalere Health delivered a detailed launch strategy roadmap grounded in primary and secondary research. Company used the roadmap to guide HEOR launch activities.
Discover more
Our people
